
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Relx PLC ADR (RELX)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: RELX (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $56.45
1 Year Target Price $56.45
1 | Strong Buy |
0 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 17.91% | Avg. Invested days 53 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 85.56B USD | Price to earnings Ratio 33.47 | 1Y Target Price 56.45 |
Price to earnings Ratio 33.47 | 1Y Target Price 56.45 | ||
Volume (30-day avg) 2 | Beta 0.43 | 52 Weeks Range 43.50 - 56.03 | Updated Date 09/16/2025 |
52 Weeks Range 43.50 - 56.03 | Updated Date 09/16/2025 | ||
Dividends yield (FY) 1.38% | Basic EPS (TTM) 1.4 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.19% | Operating Margin (TTM) 30.86% |
Management Effectiveness
Return on Assets (TTM) 12.38% | Return on Equity (TTM) 72.05% |
Valuation
Trailing PE 33.47 | Forward PE 24.15 | Enterprise Value 95219243978 | Price to Sales(TTM) 8.97 |
Enterprise Value 95219243978 | Price to Sales(TTM) 8.97 | ||
Enterprise Value to Revenue 7.36 | Enterprise Value to EBITDA 19.53 | Shares Outstanding 1825939968 | Shares Floating 1816815876 |
Shares Outstanding 1825939968 | Shares Floating 1816815876 | ||
Percent Insiders - | Percent Institutions 4.52 |
Upturn AI SWOT
Relx PLC ADR

Company Overview
History and Background
Relx PLC ADR (RELX) traces its origins to the merger of Reed Elsevier in 1992. Reed Elsevier, in turn, comprised of Reed International and Elsevier. Over time, RELX has transformed from a print publishing giant into a leading provider of information and analytics.
Core Business Areas
- Risk: Provides data, analytics, and technology to help businesses and governments assess and manage risk, detect fraud, and comply with regulations. This segment includes insurance, business services, and government solutions.
- Scientific, Technical & Medical: Delivers information, analytics, and workflow solutions to researchers and healthcare professionals. Includes scientific journals, databases, and decision support tools.
- Legal: Offers legal information, analytics, and workflow solutions to legal professionals and law firms. This includes legal research platforms and practice management tools.
- Exhibitions: Organizes trade shows and exhibitions across various industries, facilitating networking and business development.
Leadership and Structure
Relx PLC is led by a board of directors and a management team. The CEO is Sir Anthony Habgood (Chairman) and Erik Engstrom (CEO until 2024). The organizational structure is divided into the aforementioned business segments, each with its own leadership and operational teams.
Top Products and Market Share
Key Offerings
- LexisNexis: A leading legal research and information service. Market share is significant in the legal information industry, competing with Thomson Reuters (TRI) and Wolters Kluwer. Estimates are around 20-30% of the legal information market. Revenue from LexisNexis is a substantial portion of RELX's total revenue.
- ScienceDirect: A leading platform for scientific, technical, and medical research, providing access to millions of research articles. Competitors include Wiley (WLY), Springer Nature, and Taylor & Francis. Usage is widespread among researchers globally, but precise market share data is more difficult to obtain than in legal information.
- Accuity: Offer screening and payment solutions. Market share data varies geographically but competes with Dow Jones Risk & Compliance and other providers.
- Elsevier: One of the world's major providers of scientific, technical, and medical information and services. Competitors are Springer Nature, Wiley, and Taylor & Francis.
Market Dynamics
Industry Overview
The industries RELX operates in (legal, scientific, risk, and exhibitions) are characterized by increasing digitization, growing demand for data analytics, and globalization. The legal and scientific publishing industries are relatively consolidated, while the risk management and exhibitions sectors are more fragmented.
Positioning
RELX is positioned as a leading provider of information and analytics, with a strong focus on technology and innovation. Its competitive advantages include its extensive data assets, strong brands, and global reach.
Total Addressable Market (TAM)
The estimated TAM for RELX's combined business areas is in the hundreds of billions of dollars annually. This includes legal, scientific, risk management, and exhibitions. RELX is well-positioned with leading market positions in several segments to capture a significant share of this TAM.
Upturn SWOT Analysis
Strengths
- Strong brands (LexisNexis, ScienceDirect)
- Extensive data assets
- Global reach
- Recurring revenue model
- Diversified business segments
Weaknesses
- Exposure to economic cycles (especially exhibitions)
- Potential disruption from open access initiatives
- Complexity of large organization
- Dependence on data quality
Opportunities
- Expansion into new geographies
- Growth in data analytics and AI
- Acquisitions of complementary businesses
- Development of new products and services
Threats
- Competition from new entrants
- Economic downturn
- Changes in regulation
- Cybersecurity risks
- Open Access Initiatives
Competitors and Market Share
Key Competitors
- TRI
- WK
- MTH
Competitive Landscape
RELX competes effectively with TRI, WK, and smaller players. RELX's strengths include its diversified business model and strong brands. Competitors may have advantages in specific market segments.
Major Acquisitions
Emailage
- Year: 2020
- Acquisition Price (USD millions): 50
- Strategic Rationale: Expanded RELX's risk and fraud prevention capabilities by adding Emailage's email risk assessment technology.
Growth Trajectory and Initiatives
Historical Growth: RELX has demonstrated steady growth in revenue and earnings over the past decade, driven by organic growth and strategic acquisitions.
Future Projections: Analysts project continued growth for RELX, driven by demand for its information and analytics solutions. Revenue growth is expected to be in the mid-single digits, and earnings per share is expected to grow at a faster rate.
Recent Initiatives: Recent initiatives include investments in AI and machine learning, expansion into new markets, and the development of new products and services.
Summary
RELX PLC ADR appears to be a strong company with a diversified portfolio of information and analytics businesses. Its strong brands and recurring revenue model are working well. It should look out for increasing competition and potential disruption from open access initiatives. Continued investments in AI and expansion into new markets should support future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Market Research Reports
- RELX Investor Relations
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Relx PLC ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1994-10-07 | CEO & Executive Director Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | ||
Sector Industrials | Industry Specialty Business Services | Full time employees 36000 | Website https://www.relx.com |
Full time employees 36000 | Website https://www.relx.com |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.